Biotech Company Achieves Milestone Vaccine Partnership With Merck

Evaxion Biotech and MSD Achieve Milestone in Vaccine Collaboration.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

In recent biotechnology news, Evaxion Biotech A/S (NASDAQ: EVAX), a leading player in the field of artificial intelligence immunotherapies, has successfully completed the initial phases of its ongoing vaccine …